“…Concern over hypotension has been a predominant force driving the adoption of the blood pressure (BP)-sparing agent etomidate as a preferred agent for HEMS crew airway management [7]. Despite some lingering debate over etomidate's safety in some patient subsets, the imidazole hypnotic has been a top choice for air medical providers [1,8,9]. Although its potential use in situations in which NMB is contraindicated contributes to etomidate's widespread use, the main advantage of the drug is its maintenance of peri-ETI BP in critically ill and injured patients [7,[10][11][12][13][14].…”